<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR810.html">Part 810
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 810.17  Termination of a cease distribution and notification
                            </h3>
                            <p class="depth1"><em>(a)</em> The person named in a cease distribution and notification order  issued under Sec. 810.10 or a mandatory recall order issued under Sec.  810.13 may request termination of the order by submitting a written  request to FDA. The person submitting a request shall certify that he or  she has complied in full with all of the requirements of the order and  shall include a copy of the most current status report submitted to the  agency under Sec. 810.16. A request for termination of a recall order  shall include a description of the disposition of the recalled device.</p><p class="depth1"><em>(b)</em> FDA may terminate a cease distribution and notification order  issued under Sec. 810.10 or a mandatory recall order issued under Sec.  810.13 when the agency determines that the person named in the order:</p><p class="depth2"><em>(1)</em> Has taken all reasonable efforts to ensure and to verify that  all health professionals, device user facilities, consignees, and, where  appropriate, individuals have been notified of the cease distribution  and notification order, and to verify that they have been instructed to  cease use of the device and to take other appropriate action; or</p><p class="depth2"><em>(2)</em> Has removed the device from the market or has corrected the  device so that use of the device would not cause serious, adverse health  consequences or death.</p><p class="depth1"><em>(c)</em> FDA will provide written notification to the person named in the  order when a request for termination of a cease distribution and  notification order or a mandatory recall order has been granted or  denied. FDA will respond to a written request for termination of a cease  distribution and notification or recall order within 30 working days of  its receipt.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
